Distribution and antifungal susceptibility of Candida clinical isolations coming from six health care centers in the metropolitan area of Caracas, Venezuela (years 2003-2005)

scientific article

Distribution and antifungal susceptibility of Candida clinical isolations coming from six health care centers in the metropolitan area of Caracas, Venezuela (years 2003-2005) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1130-1406(08)70005-6
P698PubMed publication ID18338922
P5875ResearchGate publication ID237506970

P2093author name stringMaría Mercedes Panizo
Xiomara Moreno
Alberto Calvo
Vivian Vergara
Carolina Macero
Juana Papatzikos
María José Mendoza
Maribel E Dolande Franco
Sofía Selgrad
Vera Reviákina
P2860cites workPrevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, CanadaQ33971521
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazoleQ34041596
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).Q34680831
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategyQ36540976
Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patternsQ42165493
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.Q42561331
Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitalsQ44529489
Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year periodQ45097428
Traditional microbiological diagnosis for invasive candidiasis in critical non-neutropenic patientsQ45123004
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.Q50700185
Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.Q54063081
Comparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findingsQ73892686
[Importance of invasive candidiasis in critical non-neutropenic patients]Q82653825
[Clinical spectrum of invasive candidiasis in critically ill non-neutropenic patients]Q82653833
[Epidemiology of candidemia in ICU]Q82653839
P433issue1
P921main subjectVenezuelaQ717
P304page(s)17-21
P577publication date2008-03-01
P1433published inRevista iberoamericana de micologiaQ27719516
P1476titleDistribution and antifungal susceptibility of Candida clinical isolations coming from six health care centers in the metropolitan area of Caracas, Venezuela (years 2003-2005)
P478volume25

Reverse relations

cites work (P2860)
Q37450019Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis
Q38711698Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.
Q48523172Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.

Search more.